TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BOLD

Boundless Bio, Inc.

Healthcare · Biotechnology

2.80$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Boundless Bio, Inc. (BOLD): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/07/2026
Earnings surprise by quarter (%)
Q3 19 · 6.5 % 19 Q1 24 · -2,626.7 % 24 Q2 24 · 4.9 % 24 Q3 24 · 0.0 % 24 Q4 24 · 11.9 % 24 Q1 25 · 2.7 % 25 Q2 25 · -7.7 % 25 Q3 25 · -17.0 % 25 Q4 25 · 50.0 % 25 Q1 26 · -17.7 % 26 Q2 26 · -82.8 % 26

EPS estimate beaten

Full history 11 of 25 quarters (44%)
Last 16 quarters 7 of 16 quarters (44%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/28/2026 Boundless Bio, Inc. (BOLD): Entry into a Material Definitive Agreement; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?